These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 24065301)

  • 1. Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failure.
    Deedwania P
    Drugs; 2013 Sep; 73(14):1569-86. PubMed ID: 24065301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ivabradine for Treatment of Coronary Artery Disease: From Last Chance Resort to Mainstem of a Reasoned Therapy.
    Lupi A; Rognoni A; Cavallino C; Secco GG; Rosso R; Bongo AS
    Cardiovasc Hematol Agents Med Chem; 2015; 13(1):4-9. PubMed ID: 25544120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine.
    Canet E; Lerebours G; Vilaine JP
    Ann N Y Acad Sci; 2011 Mar; 1222():90-9. PubMed ID: 21434947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of Heart Rate Slowing With Ivabradine in Patients With Systolic Heart Failure and Coronary Artery Disease.
    Borer JS; Deedwania PC; Kim JB; Böhm M
    Am J Cardiol; 2016 Dec; 118(12):1948-1953. PubMed ID: 27780557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure.
    Fox K; Ford I; Steg PG; Tardif JC; Tendera M; Ferrari R
    Am Heart J; 2013 Oct; 166(4):654-661.e6. PubMed ID: 24093844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ivabradine: beyond heart rate control.
    Riccioni G; Vitulano N; D'Orazio N
    Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Ivabradine in the Management of Angina Pectoris.
    Giavarini A; de Silva R
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):407-417. PubMed ID: 27475447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the pharmacokinetics and pharmacodynamics of ivabradine for the treatment of heart failure.
    Rosa GM; Ferrero S; Ghione P; Valbusa A; Brunelli C
    Expert Opin Drug Metab Toxicol; 2014 Feb; 10(2):279-91. PubMed ID: 24377458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Ivabradine in the Treatment of Patients With Cardiovascular Disease.
    Weeda ER; Nguyen E; White CM
    Ann Pharmacother; 2016 Jun; 50(6):475-85. PubMed ID: 26917820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ivabradine, coronary artery disease, and heart failure: beyond rhythm control.
    Scicchitano P; Cortese F; Ricci G; Carbonara S; Moncelli M; Iacoviello M; Cecere A; Gesualdo M; Zito A; Caldarola P; Scrutinio D; Lagioia R; Riccioni G; Ciccone MM
    Drug Des Devel Ther; 2014; 8():689-700. PubMed ID: 24940047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The efficacy of ivabradine in chronic heart failure (review)].
    Isakadze A; Makharadze T; Gvishiani M
    Georgian Med News; 2015 Apr; (241):44-9. PubMed ID: 25953938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the Funny Current Inhibitor Ivabradine in Cardiac Pharmacotherapy: A Systematic Review.
    Petite SE; Bishop BM; Mauro VF
    Am J Ther; 2018; 25(2):e247-e266. PubMed ID: 26910057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Role of Ivabradine in Stable Coronary Artery Disease Without Heart Failure.
    Porres-Aguilar M; Muñoz OC; Abbas A
    Curr Cardiol Rep; 2016 Feb; 18(2):13. PubMed ID: 26768739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ivabradine in coronary heart disease: experimental and clinical pharmacology].
    Pathak A; Berdeaux A; Mulder P; Thuillez C
    Therapie; 2010; 65(5):483-9. PubMed ID: 21144484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ivabradine in Management of Heart Failure: a Critical Appraisal.
    Orasanu G; Al-Kindi SG; Oliveira GH
    Curr Heart Fail Rep; 2016 Feb; 13(1):60-9. PubMed ID: 26797824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ivabradine on cardiovascular outcomes in patients with stable angina: meta-analysis of randomized clinical trials.
    Mengesha HG; Weldearegawi B; Petrucka P; Bekele T; Otieno MG; Hailu A
    BMC Cardiovasc Disord; 2017 Apr; 17(1):105. PubMed ID: 28454527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ivabradine: a new frontier in the treatment of stable coronary artery disease and chronic heart failure.
    Gammone MA; Riccioni G; D'Orazio N
    Clin Ter; 2020; 171(5):e449-e453. PubMed ID: 32901791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate control with ivabradine: angina pectoris and beyond.
    Parakh N; Bhargava B
    Am J Cardiovasc Drugs; 2011; 11(1):1-12. PubMed ID: 21090826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical results of I(f) current inhibition by ivabradine.
    Tardif JC
    Drugs; 2007; 67 Suppl 2():35-41. PubMed ID: 17999562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of Ivabradine in Patients With Stable Coronary Artery Disease With and Without Left Ventricular Dysfunction.
    Cammarano C; Silva M; Comee M; Donovan JL; Malloy MJ
    Clin Ther; 2016 Feb; 38(2):387-95. PubMed ID: 26839043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.